Overview

Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar

Status:
Terminated
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the feasibility of treating relapsed follicular lymphoma with a combination of Bexxar and External Beam Radiotherapy (EBRT). Patients will receive EBRT (20 Gy in 10 fractions) followed by Bexxar.
Phase:
Phase 2
Details
Lead Sponsor:
University of Florida
Collaborator:
GlaxoSmithKline
Treatments:
Iodine
Iodine-131 anti-B1 antibody
Tositumomab I-131